Indeed, rs11136000 (T) has been described to increase cerebral ApoJ expression in AD patients and controls (Allen et al., 2012; Ling et al., 2012), although studies regarding its impact on plasma levels have found different results (Schürmann et al., 2011; Mullan et al., 2013). Here, CLU is linked to Alzheimer disease.